Bernstein Maintains Outperform on Biohaven, Raises Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst William Pickering has maintained an 'Outperform' rating on Biohaven (NYSE:BHVN) and raised the price target from $55 to $66.
September 24, 2024 | 5:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bernstein analyst William Pickering has maintained an 'Outperform' rating on Biohaven and increased the price target from $55 to $66, indicating confidence in the company's future performance.
The increase in price target from $55 to $66 by a reputable analyst suggests a positive outlook for Biohaven, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100